Filing Details

Accession Number:
0000950170-25-036774
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-10 21:44:50
Reporting Period:
2025-03-10
Filing Date:
2025-03-10
Accepted Time:
2025-03-10 21:44:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1858848 Tenaya Therapeutics Inc. TNYA Biological Products, (No Disgnostic Substances) (2836) 813789973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2054280 Tomohiro Higa C/O Tenaya Therapeutics, Inc.
171 Oyster Point Blvd., 5Th Floor
South San Francisco CA 94080
Svp, Finance No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-03-10 1,017 $0.54 101,155 No 4 S Direct
Common Stock Disposition 2025-03-10 620 $0.54 100,535 No 4 S Direct
Common Stock Disposition 2025-03-10 845 $0.54 99,690 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on October 15, 2022.
  2. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Includes 69,345 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
  4. Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
  5. Includes 67,938 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
  6. Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
  7. Includes 66,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.